BenzotetramisoleCAS# 885051-07-0 |
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
Cas No. | 885051-07-0 | SDF | Download SDF |
PubChem ID | 11557884 | Appearance | Powder |
Formula | C15H12N2S | M.Wt | 252.3 |
Type of Compound | N/A | Storage | Desiccate at -20°C |
Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
Chemical Name | (2R)-2-phenyl-1,2-dihydroimidazo[2,1-b][1,3]benzothiazole | ||
SMILES | C1C(N=C2N1C3=CC=CC=C3S2)C4=CC=CC=C4 | ||
Standard InChIKey | YGCWPCVAVSIFLO-LBPRGKRZSA-N | ||
Standard InChI | InChI=1S/C15H12N2S/c1-2-6-11(7-3-1)12-10-17-13-8-4-5-9-14(13)18-15(17)16-12/h1-9,12H,10H2/t12-/m0/s1 | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Benzotetramisole Dilution Calculator
Benzotetramisole Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 3.9635 mL | 19.8177 mL | 39.6354 mL | 79.2707 mL | 99.0884 mL |
5 mM | 0.7927 mL | 3.9635 mL | 7.9271 mL | 15.8541 mL | 19.8177 mL |
10 mM | 0.3964 mL | 1.9818 mL | 3.9635 mL | 7.9271 mL | 9.9088 mL |
50 mM | 0.0793 mL | 0.3964 mL | 0.7927 mL | 1.5854 mL | 1.9818 mL |
100 mM | 0.0396 mL | 0.1982 mL | 0.3964 mL | 0.7927 mL | 0.9909 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Farrerol 7-O-glucoside
Catalog No.:BCN6412
CAS No.:885044-12-2
- Manassantin A
Catalog No.:BCC8207
CAS No.:88497-87-4
- Artesunate
Catalog No.:BCN2457
CAS No.:88495-63-0
- Murraxocin
Catalog No.:BCN4431
CAS No.:88478-44-8
- (E)-FeCP-oxindole
Catalog No.:BCC6078
CAS No.:884338-18-5
- Buparvaquone
Catalog No.:BCC5437
CAS No.:88426-33-9
- 6,7-Dihydroxycoumarin-4-Acetic Acid
Catalog No.:BCC9205
CAS No.:88404-14-2
- L-(-)-α-Methyldopa hydrochloride
Catalog No.:BCC4083
CAS No.:884-39-9
- Methyl syringate
Catalog No.:BCN4430
CAS No.:884-35-5
- AZD2932
Catalog No.:BCC6388
CAS No.:883986-34-3
- 8alpha-(2-Methylacryloyloxy)-1-O-methylhirsutinolide 13-O-acetate
Catalog No.:BCN7106
CAS No.:883872-71-7
- 8-Lavandulylkaempferol
Catalog No.:BCN3961
CAS No.:883859-83-4
- ARRY-520 R enantiomer
Catalog No.:BCC1368
CAS No.:885060-08-2
- ARRY 520 trifluoroacetate
Catalog No.:BCC2391
CAS No.:885060-09-3
- Dichotomitin
Catalog No.:BCN8524
CAS No.:88509-91-5
- GW9508
Catalog No.:BCC1102
CAS No.:885101-89-3
- LY 2389575 hydrochloride
Catalog No.:BCC7985
CAS No.:885104-09-6
- Rosamultin
Catalog No.:BCN7391
CAS No.:88515-58-6
- W-13 hydrochloride
Catalog No.:BCC6620
CAS No.:88519-57-7
- Kongensin A
Catalog No.:BCN4432
CAS No.:885315-96-8
- MK-8745
Catalog No.:BCC3994
CAS No.:885325-71-3
- HJC 0350
Catalog No.:BCC6302
CAS No.:885434-70-8
- Minumicrolin
Catalog No.:BCN4433
CAS No.:88546-96-7
- CCT128930
Catalog No.:BCC3904
CAS No.:885499-61-6
Enantioselective Cascade Reaction for Synthesis of Quinolinones through Synergistic Catalysis Using Cu-Pybox and Chiral Benzotetramisole as Catalysts.[Pubmed:28425212]
Chemistry. 2017 Jun 7;23(32):7689-7693.
In contrast to the well-studied asymmetric catalyzed synthesis of tetrahydroquinolines, the asymmetric methodologies toward 3,4-dihydroquinolin-2-ones are quite rare. Herein, the first asymmetric cascade reaction is reported between ethynyl benzoxazinanones and mixed-anhydrides generated from aryl acetic acids and pivaloyl chloride, based on synergistic catalysis. This allowed the formation of attractive 3,4-dihydroquinolin-2-ones bearing two vicinal chiral centers at C3 and C4 in high yields with excellent diastereo- and enantioselectivities. A plausible chiral induction model for this reaction was proposed. The utility of this methodology was exemplified by further elaboration of the cyclization products by removal of the N-protecting groups.
An isothiourea-catalyzed asymmetric [2,3]-rearrangement of allylic ammonium ylides.[Pubmed:24588738]
J Am Chem Soc. 2014 Mar 26;136(12):4476-9.
Benzotetramisole promotes the catalytic asymmetric [2,3]-rearrangement of allylic quaternary ammonium salts (either isolated or prepared in situ from p-nitrophenyl bromoacetate and the corresponding allylic amine), generating syn-alpha-amino acid derivatives with excellent diastereo- and enantioselectivity (up to >95:5 dr; up to >99% ee).